14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ABVX vs FOFO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Abivax SA (ABVX) captures the overall head-to-head institutional edge over Hang Feng Technology Innovation Co., Ltd. (FOFO) on higher Unified Composite conviction (42.4/100 HOLD vs. 43.0/100 HOLD) after splitting the core matrix 4–3 (led by Growth & Scale), while FOFO wins 3–1 across the 6-pillar growth and valuation breakdown. ABVX trades at $73.20 (N/M Forward P/E, -6270.4% operating margin) versus FOFO at $1.50 (N/M Forward P/E, -823.6% operating margin).
Composite vs. Pillar Nuance: While FOFO currently prints a higher short-term Unified Composite Score (43.0/100 HOLD vs. ABVX 42.4/100 HOLD), ABVX captures the overall institutional head-to-head verdict (4–3 matrix metrics and 1–3 across the 6 pillars) due to superior fundamental profitability (-6270.4% vs. -823.6% operating margin) and revenue trajectory (-6.8% vs. -72.7% YoY).
Technical & Structure Timing Caution: ABVX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile FOFO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs FOFO. Trailing 12-month operating profitability (ABVX -6270.4% vs FOFO -823.6%) and valuation multiples (ABVX N/M vs FOFO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consulting Services value chain with $12.8M market capitalization and -823.6% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ABVX vs FOFO Key Questions & Quantitative Answers
As of Nov 20, 2026, Abivax SA (ABVX) captures the overall head-to-head institutional edge over Hang Feng Technology Innovation Co., Ltd. (FOFO) on higher Unified Composite conviction (42.4/100 HOLD vs. 43.0/100 HOLD) after splitting the core matrix 4–3 (led by Growth & Scale), while FOFO wins 3–1 across the 6-pillar growth and valuation breakdown. ABVX trades at $73.20 (N/M Forward P/E, -6270.4% operating margin) versus FOFO at $1.50 (N/M Forward P/E, -823.6% operating margin). Composite vs. Pillar Nuance: While FOFO currently prints a higher short-term Unified Composite Score (43.0/100 HOLD vs. ABVX 42.4/100 HOLD), ABVX captures the overall institutional head-to-head verdict (4–3 matrix metrics and 1–3 across the 6 pillars) due to superior fundamental profitability (-6270.4% vs. -823.6% operating margin) and revenue trajectory (-6.8% vs. -72.7% YoY). Technical & Structure Timing Caution: ABVX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile FOFO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABVX leads the Growth & Scale pillar: ABVX posts -6.8% YoY revenue growth and +0.0% YoY earnings growth on $4.7M TTM revenue (100.0% gross margin, -6270.4% operating margin), compared with FOFO at -72.7% YoY revenue growth and +0.0% YoY earnings growth on $1.4M TTM revenue (7.0% gross margin, -823.6% operating margin). On trailing 12-month operating scale, ABVX generates $4.7M in USD-normalized revenue versus $1.4M for FOFO. In operating R&D and SG&A reinvestment, ABVX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FOFO.
FOFO screens cheaper on headline valuation multiples. ABVX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin), whereas FOFO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.4x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVX (-252.3% ROE) versus FOFO (-169.2% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVX carries 76.9% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.55β · 55% Vol realized risk). By comparison, FOFO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 65% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.